Industry

DUBLIN–(BUSINESS WIRE)–The “Global Spinal Fusion Devices Market Size, Share & Industry Trends Analysis Report By Surgery, By Type, By End User (Hospitals, Specialty Clinics, and Others), By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Spinal Fusion Devices Market size is expected to reach $9.7 billion by … [Read more…]

VS-01 Reduced Plasma Metabolites Associated with Organ Failures Related to ACLF Metabolomic analysis of organ failure markers abstract selected for inclusion in the ‘Best of International Liver Congress™ 2022’ ZURICH–(BUSINESS WIRE)–Versantis, a clinical-stage biotechnology company developing novel therapies for orphan and pediatric liver diseases, today announced data showing both single and repeated intraperitoneal administrations of … [Read more…]

Largest multinational survey highlights impact of pruritus on quality of life for patients with primary sclerosing cholangitis FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) presented data at the International Liver Congress™ of The European Association for the Study of the Liver (EASL) in London, United Kingdom. The first analysis featured a multinational survey of … [Read more…]

LONDON–(BUSINESS WIRE)–SC1, London’s new Life Sciences Innovation District being developed in south central London, UK, has announced the appointment of a new Executive Director, Georgina Rizik. Georgina is a leading international healthcare and biotechnology commercial executive with over 25 years’ experience across private, public and non-profit organisations. Starting in June, Georgina will lead SC1, which … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation of CEO Nawal Ouzren in the LifeSci Partners 2nd Annual Genetic Medicines Symposium being held … [Read more…]

BASEL, Switzerland–(BUSINESS WIRE)–Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases, announced today that it will host a key opinion leader (KOL) event for investors in Zurich on Monday, June 27, starting at 12:15 pm … [Read more…]

TORONTO–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced certain changes to its board of directors (the “Board”) and the postponement of its annual general meeting of shareholders, originally scheduled to take place on June 24, 2022 (the “Meeting”). Effective immediately, the Board has been reconstituted, by shareholder resolution, to consist of Tej Virk, Harvinder … [Read more…]

DENVER–(BUSINESS WIRE)–The Denver Health and Hospital Authority Board of Directors has announced that Donna Lynne, DrPH, will serve as the next chief executive officer (CEO) to lead Denver Health. “We are confident that Donna’s extensive operational and leadership experience, her deep connections to our Colorado communities and her passion for our mission as a safety-net … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Technical Safety Services (TSS), a portfolio company of The Edgewater Funds (Edgewater) and JZ Partners (JZ), on its sale to Levine Leichtman Capital Partners (LLCP). TSS is a leading provider of testing, inspection, certification, and calibration (TICC) services to … [Read more…]

Data shows patients surveyed had low decision regret1 after testing with DecisionDx®-UM, regardless of whether their uveal melanoma tumor was at high or low risk of metastasis FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced findings from a study that evaluated uveal … [Read more…]